Joseph Onyeanu
Delivering high-quality clinical trials. Strengthening research sites. Building partnerships that make studies possible.
I am a Clinical Research Associate with 8+ years of experience supporting and managing Phase II–IV multicenter clinical trials across hematology, nephrology, neurology, cardiovascular disease, and medical device research.
My career has grown from hands-on clinical trial operations to independent site management and clinical monitoring, and more recently into strategic site alliance leadership across Sub-Saharan Africa.
What I bring is a combination of clinical operations expertise and a practical understanding of what makes research sites ready, capable, and successful.
Clinical research has been the foundation of my career.
I began in clinical trial operations, supporting study start-up, regulatory documentation, TMF and CTMS management, investigator meetings, and site activities. That foundation progressed into a Senior CRA role, where I have managed investigative sites, conducted monitoring visits, assessed site performance, identified risks, and worked with cross-functional teams to keep studies moving.
Today, alongside my Senior CRA responsibilities, I also lead strategic site alliance initiatives. This expanded role has allowed me to work beyond individual study sites—building relationships with investigators and institutions, assessing research capabilities, supporting sponsor feasibility assessments, and helping to expand access to trial-ready sites across Africa.
That combination is central to how I approach clinical research:
Understand the study. Understand the site. Understand the people. Then build the conditions for successful delivery.
Clinical Trial Delivery
I manage and monitor Phase II–IV clinical trials across the study lifecycle, from feasibility and site activation through monitoring and close-out.
My experience includes:
- Site Qualification Visits
- Site Initiation Visits
- Interim and Routine Monitoring Visits
- Close-Out Visits
- Source Data Verification
- Source Document Review
- Risk-Based Monitoring / RBQM
- Protocol compliance
- Patient safety oversight
- SAE documentation and reporting
- CAPA management
- Inspection readiness
I have managed portfolios of 8–10 investigative sites and supported 7+ international Phase II–IV multicenter clinical trials.
Site & Investigator Management
A successful clinical trial depends heavily on the quality and readiness of its sites.
I work closely with investigators and site teams to understand operational challenges, identify risks early, strengthen compliance, and support study milestones.
My experience includes:
- Site feasibility and capability assessment
- Site selection and qualification
- Site activation
- Investigator relationship management
- Site performance oversight
- Investigator and site training
- Recruitment support
- Regulatory documentation
- Protocol implementation
- Site issue resolution
I place particular value on communication. Whether working with an investigator, sponsor, project manager, or site coordinator, my approach is to understand the issue, communicate clearly, and work toward a practical solution.
Connecting research-ready sites with opportunities to conduct better clinical research.
Since January 2026, I have held an expanded strategic site alliance leadership responsibility alongside my Senior CRA role.
This work has taken my experience beyond individual study monitoring and into the broader clinical research ecosystem across Africa.
I establish and manage research partnerships with clinical research institutions across 10 African countries, assessing investigator expertise, patient recruitment potential, laboratory capability, infrastructure, regulatory readiness, and overall site capability.
I also work with Principal Investigators, Key Opinion Leaders, research administrators, and institutional leadership to build relationships that can support future clinical research opportunities.
A measurable outcome
35%
Increase in organizational access to experienced investigators, specialized patient populations, and trial-ready research sites within 90 days.
This experience has given me a broader perspective on clinical trial delivery—one that considers not only whether a site can participate in a study, but whether the right conditions exist for that site to perform successfully.
2017–2019
Clinical Trial Associate
XCENE Research
I began my clinical research career supporting global and multicenter clinical trials.
My early experience included study start-up support, regulatory documentation, TMF and CTMS maintenance, investigator meeting coordination, site activation activities, document quality control, and co-monitoring.
This experience gave me a strong operational foundation and an appreciation for the importance of getting the details right from the beginning.
2022–Present
Senior Clinical Research Associate
XCENE Research
My role evolved into independent clinical monitoring and site management across Phase II–IV multicenter studies.
I have managed investigative sites across Nigeria and Sub-Saharan Africa, conducted monitoring visits, performed SDV/SDR and RBM/RBQM activities, maintained inspection-ready documentation, managed site risks, supported patient safety, and worked closely with sponsors and cross-functional study teams.
I have also mentored 5+ junior CRAs, helping strengthen monitoring quality, regulatory compliance, and team performance.
2026–Present
Strategic Site Alliance Leadership
XCENE Research
An expanded responsibility alongside my Senior CRA role.
I now apply my clinical research experience to site development, investigator engagement, research partnerships, feasibility intelligence, and expansion of trial-ready research capacity across Africa.
8+
Years in Clinical Research
II–IV
Multicenter Clinical Trial Experience
7+
International Clinical Trials
8–10
Investigative Sites Managed
35%
Increase in Access to Trial-Ready Sites & Investigators
5+
Junior CRAs Mentored
100%
Audit-Ready Study Documentation
My clinical research experience spans multiple therapeutic areas, giving me exposure to different patient populations, study designs, site environments, and operational considerations.
PHASE II–III
Hematology
Sickle Cell Disease
PHASE II/III
Nephrology
APOL1-Mediated Kidney Disease
PHASE IIIB
Neurology
Stroke Prevention
PHASE III
Cardiovascular
Cardiovascular Disease
PHASE III
Medical Devices
Medical Device Clinical Studies
Rare Disease
Experience supporting clinical research involving rare disease populations.
“
I communicate early.
Clinical trial issues rarely improve when they are allowed to sit unresolved. I believe in clear, timely communication with sites, sponsors, and cross-functional teams.
“
I look beyond the immediate problem.
Whether it is a protocol deviation, documentation gap, recruitment challenge, or site performance issue, I try to understand the underlying cause—not just close the immediate action.
“
I build relationships.
Strong investigator and site relationships are essential to successful clinical research. I work to establish credibility through consistency, responsiveness, and understanding of the site's realities.
“
I care about quality.
Patient safety, data integrity, protocol compliance, and regulatory standards are not separate from operational delivery. They are the foundation of it.
“
I think strategically.
My expanded site alliance role has strengthened my ability to look beyond individual studies and consider how research capacity, investigator networks, infrastructure, patient populations, and institutional readiness influence clinical trial delivery.
Knowledge
- ICH-GCP, FDA, EMA and international clinical research regulations
- Phase II–IV clinical trial lifecycle
- Site feasibility and investigator assessment
- RBQM and risk-based monitoring
- Good Documentation Practice
- TMF and CTMS management
- Inspection readiness
- Patient safety and ethical conduct of clinical research
- Clinical research across hematology, nephrology, neurology, cardiovascular disease, medical devices and rare disease
Skills
- Clinical trial monitoring
- Site management
- SDV and source document review
- Protocol compliance
- Risk identification and mitigation
- CAPA management
- Regulatory documentation
- CTMS and eTMF systems
- Investigator engagement
- Cross-functional collaboration
- Written and verbal communication
- Site and investigator training
- CRA mentorship
- Strategic site partnerships
Abilities
- Independently manage multiple investigative sites throughout the clinical trial lifecycle.
- Identify operational and compliance risks and implement practical mitigation strategies.
- Build productive relationships with investigators, sponsors, CROs and institutional stakeholders.
- Integrate clinical monitoring expertise with strategic site alliance leadership to strengthen investigator engagement and expand trial-ready research capacity across Sub-Saharan Africa.
- Maintain high standards of patient safety, data integrity, regulatory compliance and study quality.
MBA — Clinical Research Management
Rushford Business School
Expected Autumn 2026
Bachelor of Technology — Biotechnology
Federal University of Technology, Owerri
2012
Professional Certifications
Good Clinical Practice (GCP)
Association of Clinical Research Professionals
2026
Strategic Leadership
London School of Business Administratio
2025
Clinical Research
Regulatory & Quality
Productivity
My career has taught me that successful clinical research is not only about monitoring against a protocol It is also about people.
It is about understanding investigators and site teams, recognizing operational realities, identifying risks early, communicating clearly, and creating an environment where sites can perform.
My experience across clinical monitoring and strategic site alliance development has allowed me to see clinical research from both sides: the requirements of the study and the realities of the site.
That perspective is what I bring to every study and every partnership.